Research and Development Arrangement, Contract to Perform for Others, Minimum Annual Royalty Payment

No definition available.

Name:	kids_ResearchandDevelopmentArrangementContracttoPerformforOthersMinimumAnnualRoyaltyPayment
Namespace Prefix:	kids_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Research and Development Arrangement, Contract to Perform for Others, Royalty Agreement, Ability to Sell, Milestone Payment

+ References

No definition available.

+ Details

Name:	kids_ResearchandDevelopmentArrangementContracttoPerformforOthersRoyaltyAgreementAbilitytoSellMilestonePayment
Namespace Prefix:	kids_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Research and Development Arrangement, Contract to Perform for Others, Royalty Agreement, Percent

+ References

No definition available.

+ Details

Name:	kids_ResearchandDevelopmentArrangementContracttoPerformforOthersRoyaltyAgreementPercent
Namespace Prefix:	kids_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Research and Development Arrangement, Contract to Perform for Others, Royalty Agreement, Product Launch, Milestone Payment

+ References

No definition available.

+ Details

Name:	kids_ResearchandDevelopmentArrangementContracttoPerformforOthersRoyaltyAgreementProductLaunchMilestonePayment
Namespace Prefix:	kids_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Research and Development Arrangement, Contract to Perform for Others, Term

+ References

No definition available.

+ Details

Name:	kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm
Namespace Prefix:	kids_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_AccruedRoyaltiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045

+ Details

Name:	us-gaap_ContractWithCustomerLiabilityNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a),(d))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

+ Details

Name:	us-gaap_CostOfGoodsAndServicesSold
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_RoyaltyAgreementTermsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=kids_CaseWesternReserveUniversityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=us-gaap_RoyaltyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

STRATEGIC ARRANGEMENTS (Details) - USD ($)			12 Months Ended
STRATEGIC ARRANGEMENTS (Details) - USD ($)	Aug. 02, 2017	Dec. 01, 2007	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Minimum annual royalty payment			$ 500,000
Cost of revenue			17,933,000	$ 14,879,000	$ 11,170,000
Deferred revenue			12,410,000	0
Royalty Agreement Terms \| CASE
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Royalty agreement period	10 years	10 years
Minimum annual royalty payment			$ 10,000
Royalty agreement percentage			3.00%
Milestone payments for FDA approval to sell our products within the United States			$ 5,000
Milestone payment for general product launch			10,000
Royalty payable			39,000	36,000
Royalty \| Royalty Agreement Terms \| CASE
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Cost of revenue			$ 153,000	$ 145,000	$ 148,000